SES - Delayed Quote USD

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

Compare
2.0400
-0.0500
(-2.39%)
At close: January 10 at 4:58:45 PM GMT+8
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
10,230,100.9407
10,156,982.0394
9,067,085.0061
8,283,387.6805
Total Liabilities Net Minority Interest
3,584,864.4336
3,605,028.9006
2,553,255.8756
2,333,493.6597
Total Equity Gross Minority Interest
6,645,236.5071
6,551,953.1388
6,513,829.1305
5,949,894.0208
Total Capitalization
6,841,725.4064
6,672,760.0697
6,364,477.5750
5,838,408.8945
Common Stock Equity
6,600,690.5426
6,521,460.5350
6,364,477.5750
5,808,408.8945
Capital Lease Obligations
2,742.6568
871.4268
1,571.6315
1,709.7903
Net Tangible Assets
6,203,954.2082
6,144,637.8813
6,161,569.1071
5,604,386.1290
Working Capital
3,318,751.9407
3,912,009.8883
3,991,091.4643
3,439,750.7103
Invested Capital
6,923,525.4064
6,774,398.5849
6,364,477.5750
5,838,408.8945
Tangible Book Value
6,203,954.2082
6,144,637.8813
6,161,569.1071
5,604,386.1290
Total Debt
329,141.6675
257,906.4236
33,168.7430
32,710.1865
Share Issued
770,158.2760
773,443.0760
773,443.0760
773,643.0760
Ordinary Shares Number
770,158.2760
773,443.0760
773,443.0760
773,643.0760
12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers